Tr-KIT/c-KIT ratio in renal cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• c-KIT protein is implicated in oncogenic processes within renal cell carcinoma (RCC).
• The specific role of truncated KIT (tr-KIT), an alternative c-KIT variant, in RCC development and progression is not well understood.
• Investigating tr-KIT's association with RCC is crucial for understanding its oncogenic pathways.

Purpose of the Study:

• To investigate the association between truncated KIT (tr-KIT) and renal cell carcinoma (RCC).
• To determine if the tr-KIT/c-KIT expression ratio correlates with clinical parameters and prognosis in RCC patients.
• To explore the potential of tr-KIT as a prognostic marker for RCC.

Main Methods:

• Gene expression analysis using a Kidney Cancer cDNA Array with 48 samples (normal and various stages of RCC).
• Real-Time PCR was employed to quantify tr-KIT/c-KIT expression ratios.
• Statistical analysis was performed to compare expression ratios between tumor and normal tissues and correlate them with clinical parameters (nuclear grade, RCC subtype).

Main Results:

• The tr-KIT/c-KIT expression ratio was approximately 4-times higher in RCC tumor samples compared to normal kidney tissues (p=0.001).
• Elevated tr-KIT/c-KIT ratios were observed in higher Fuhrman nuclear grades (2, 3, and 4) compared to normal tissues (p=0.009).
• Clear cell and papillary RCC subtypes showed significantly higher tr-KIT/c-KIT expression ratios than chromophobe RCC (p=0.016).

Conclusions:

• This study is the first to report the upregulation of the tr-KIT/c-KIT expression ratio in RCC tissues.
• A high tr-KIT/c-KIT expression ratio is associated with more aggressive clinical features and poorer patient prognosis in RCC.
• Increased tr-KIT/c-KIT expression ratio shows potential as a valuable prognostic marker for RCC patients.